How Does Alcohol Detox Work? What to Expect

Alcohol detox is the medically supervised process of clearing alcohol from your body while managing the withdrawal symptoms that follow. When someone who has been drinking heavily for weeks, months, or years suddenly stops, the brain and nervous system react forcefully, sometimes dangerously. Detox typically unfolds over a span of days to roughly two weeks, with symptoms peaking in the first few days, and its course depends heavily on how long and how much a person has been drinking.

Why Your Brain Reacts When You Stop Drinking

To understand what detox puts you through, it helps to know what alcohol has been doing to your brain in the first place. Alcohol dampens brain activity. It boosts the calming chemical GABA while suppressing glutamate, the brain’s main excitatory signal. Over time, the brain compensates by dialing GABA down and glutamate up, trying to maintain a working balance. When you abruptly remove alcohol from that equation, the brain is left in a hyper-excitable state with too much glutamate firing and not enough GABA to keep things in check.¹ That imbalance is essentially what drives withdrawal.

The disruption doesn’t stop at GABA and glutamate. Chronic alcohol exposure also alters monoamines, neuropeptide systems, and ion channels throughout the brain, and these changes don’t snap back the moment drinking stops.² On top of that, the sympathetic nervous system goes into overdrive. Studies have shown that the severity of withdrawal symptoms tracks with how much norepinephrine, the body’s “fight or flight” chemical, is being released.³ This is why tremor, racing heart, sweating, and anxiety are hallmarks of early withdrawal: your body’s alarm system is running unchecked.

The Withdrawal Timeline

Withdrawal doesn’t hit all at once. It tends to roll through in stages, though the boundaries between them blur from person to person.

Symptoms often begin within about six hours of the last drink, sometimes even while there is still measurable alcohol in the blood. In the first six to 48 hours, you can expect the milder end of the spectrum: tremor, insomnia, headache, nausea, sweating, and a general sense of agitation. During this “early withdrawal” phase, people are typically fully conscious and oriented, even if they feel terrible.⁴

If withdrawal progresses to a moderate stage, hallucinations can appear. These are most often visual or auditory, and they can occur while the person is otherwise alert and aware of their surroundings, which distinguishes them from delirium.⁴ Alcoholic hallucinosis, a related but distinct condition, involves predominantly auditory hallucinations that sometimes mimic features of psychotic disorders.⁵ These hallucinations can persist for up to six days.

Seizures are another risk, most commonly appearing 6 to 48 hours after the last drink. The most severe form of withdrawal, delirium tremens, usually develops 48 to 72 hours after cessation and can last up to two weeks. Delirium tremens involves profound confusion, disorientation, fever, and cardiovascular instability. It is a medical emergency. Not everyone progresses through every stage; many people experience only mild or moderate symptoms. But for those who do reach the severe end, the situation can be life-threatening without treatment.⁴

How Medical Teams Monitor Withdrawal

One of the biggest advantages of supervised detox is that clinicians don’t just watch and wait. They use structured assessment tools to track how severe your withdrawal is becoming and to adjust medication in real time. The most widely used is a ten-item scoring scale called the CIWA-Ar, which rates things like nausea, tremor, sweating, anxiety, and agitation on a point system. A meta-analysis confirmed that the CIWA-Ar reliably tracks the course of withdrawal over time, making it a practical guide for treatment decisions.⁶

Predicting who will develop severe withdrawal is just as important as monitoring it. A systematic review found that the Prediction of Alcohol Withdrawal Severity Scale (PAWSS) was the most useful clinical tool for identifying high-risk patients in acute care settings.⁷ Having a prior episode of delirium tremens or withdrawal seizures roughly doubles or triples the odds that the next withdrawal episode will be severe too, according to a separate meta-analysis.⁸

Medications Used During Detox

Benzodiazepines are the backbone of medical detox. They work on the same GABA system that alcohol affects, which means they can partially substitute for alcohol’s calming effect on the brain and reduce the risk of seizures, agitation, and delirium. They have the largest evidence base of any drug class for this purpose and are considered the gold standard.⁹ They replaced older and riskier sedatives like barbiturates and paraldehyde.¹⁰

Not all benzodiazepines are the same in practice. Longer-acting options like diazepam and chlordiazepoxide provide a smoother withdrawal because the drug itself tapers gradually in the body. Shorter-acting ones like lorazepam and oxazepam don’t linger as long, which can be safer in people whose livers are already damaged by years of heavy drinking.¹¹ In patients with liver disease, the processing of many drugs through the liver is impaired, but lorazepam and oxazepam use a metabolic pathway (glucuronidation) that stays relatively intact even when the liver is struggling.¹²

There are two main dosing strategies. In a “fixed-dose” approach, you get a set amount of medication on a schedule that tapers down over several days. In a “symptom-triggered” approach, you only receive medication when your symptoms cross a certain threshold on the monitoring scale. The symptom-triggered method is generally preferred because it tends to result in less total medication and shorter treatment, though it requires more frequent monitoring.⁹

Beyond benzodiazepines, clinicians often add other medications as needed. Gabapentin has anxiolytic and sedative properties and is increasingly used as an add-on to reduce benzodiazepine requirements.¹³ Clonidine can be given for significant high blood pressure during withdrawal. Antipsychotics like haloperidol are sometimes used for severe agitation and hallucinations, though they don’t protect against seizures and carry their own risks.¹⁴

Seizures and Delirium Tremens

Withdrawal seizures are one of the most feared complications. They happen because alcohol chronically raises the seizure threshold, and when it is removed, that threshold drops sharply. The brain’s glutamate and GABA systems, combined with changes in calcium flow through neurons, create a window of vulnerability in the first two days after drinking stops.¹⁵ Benzodiazepines significantly reduce the risk of first-time withdrawal seizures. In people who have already had one seizure during a withdrawal episode, lorazepam has been shown to be effective at preventing a second, while the older anticonvulsant phenytoin was not.¹⁵

Delirium tremens remains uncommon in the broader population of people going through withdrawal, but it is deadly when it does occur. A history of previous delirium tremens, a baseline systolic blood pressure at or above 140 mmHg, low platelet counts, and low potassium levels all increase the likelihood.⁷⁸ Interestingly, the same meta-analysis found that neither gender nor having liver disease on its own predicted severe withdrawal, which goes against a common assumption.⁸

What Happens to the Rest of Your Body

Detox isn’t just a brain event. Heavy drinking drains the body of key nutrients, and those deficits create their own problems during withdrawal.

Magnesium deficiency is found in roughly 30 to 60 percent of chronic heavy drinkers. Low magnesium destabilizes nerve cells and can worsen seizures, tremors, and even heart rhythm disturbances during withdrawal.¹⁶ Thiamine (vitamin B1) deficiency is another major concern, because a severe shortfall can cause Wernicke’s encephalopathy, a brain condition marked by confusion, unsteady gait, and eye-movement abnormalities. For critically ill patients with chronic alcohol use, the recommended approach has moved away from low-dose supplements in favor of high-dose intravenous thiamine, along with magnesium and folate.¹⁷

Blood pressure and heart rate also respond dramatically to both heavy drinking and its cessation. During active withdrawal, the sympathetic overdrive discussed earlier pushes both upward. But after the acute phase passes, abstinence brings meaningful improvements. One study of heavy drinkers found that blood pressure began dropping significantly by the third day of abstinence, with levels normalizing in nearly all participants within the study period.¹⁸ Another study tracked 24-hour blood-pressure monitoring over a month of proven abstinence and found that the proportion of patients classified as hypertensive fell from about 42 percent to 12 percent.¹⁹ Heart rate follows a similar pattern: elevated during active withdrawal, then settling to near-normal levels after treatment.²⁰

Inpatient Versus Outpatient Settings

Not everyone needs to detox in a hospital. Mild withdrawal in someone who is otherwise healthy, has no history of severe episodes, and has a supportive home environment can sometimes be managed on an outpatient basis with daily medical check-ins. But inpatient detox is appropriate whenever there is a risk of life-threatening complications, such as a history of delirium tremens or seizures, or when concurrent medical conditions like pancreatitis, gastrointestinal bleeding, or liver cirrhosis complications are present.²¹ In practice, the decision comes down to how predictable the withdrawal is likely to be. If there are unknowns (no prior withdrawal history to judge from, uncertain drinking quantity, other drugs involved), clinicians tend to err on the side of closer monitoring.

Pregnancy and Alcohol Withdrawal

Managing withdrawal in a pregnant person adds a layer of complexity that deserves its own discussion. The physiological stress of withdrawal, particularly the blood pressure spikes and the elevated cortisol levels, can threaten placental blood flow and fetal well-being. After about 20 weeks of pregnancy, hypertension from any cause can alter the dynamics of the placental circulatory system, and withdrawal-driven hypertension is no exception.²² For this reason, withdrawal management in pregnancy generally warrants a more intensive and carefully monitored approach than it would in other patients.

Benzodiazepines remain the recommended treatment for alcohol withdrawal during pregnancy, and psychosocial interventions have been shown to help reduce consumption and maintain abstinence in this population.²³ There is a natural concern about exposing a fetus to benzodiazepines, but the consensus is that the risks of uncontrolled withdrawal, including seizures and sustained hypertension, are far greater than the risks of short-term, supervised benzodiazepine use.

Sleep Disruption During Withdrawal

Poor sleep is one of the most persistent and underappreciated parts of detox. During acute withdrawal, total sleep time drops substantially. The composition of sleep shifts too: the deeper stages of non-REM sleep shrink, while REM sleep surges in what researchers call “REM rebound.” In animal studies, total sleep time and non-REM sleep recovered by about the fourth day of withdrawal, but the REM rebound persisted beyond that.²⁴ In practical terms, this means people going through detox often feel exhausted and report vivid, disturbing dreams. Sleep problems linger well beyond the acute phase and are themselves a risk factor for relapse, which makes addressing them part of any serious recovery plan.

Post-Acute Withdrawal and What Comes After Detox

Detox is the beginning of recovery, not the whole story. Once the acute withdrawal symptoms fade, usually within a week or two, many people enter a phase sometimes called post-acute withdrawal syndrome (PAWS). This involves a different set of symptoms: anxiety, low mood, an inability to feel pleasure, difficulty concentrating, irritability, cravings, and continued sleep problems. These can develop in early abstinence and persist for four to six months or longer.²⁵ PAWS symptoms appear to be driven by lingering neurobiological changes, including alterations in cortisol, serotonin, and brain reward circuits, and they are recognized risk factors for returning to drinking.

This is where medications for relapse prevention come in. Two drugs have the strongest evidence: naltrexone and acamprosate. They work differently. Naltrexone blocks opioid receptors and reduces the rewarding feeling of drinking, making it particularly useful for preventing heavy-drinking episodes. Acamprosate appears to modulate the glutamate system and is better at helping people who have already stopped drinking stay abstinent. In a meta-analysis, acamprosate was more effective at preventing any drinking at all, while naltrexone was better at keeping a slip from turning into a full relapse.²⁶ One trial found that combining both medications outperformed acamprosate alone, though it did not significantly outperform naltrexone alone.²⁷

Timing matters. A meta-analysis found that naltrexone showed larger effects when patients were required to be abstinent before starting the medication, and acamprosate worked better when people had completed a formal detoxification before beginning treatment.²⁸ In other words, these drugs are designed to pick up where detox leaves off. They are not substitutes for it and they are not stand-alone cures, but combined with counseling and support, they meaningfully improve the odds of staying sober.

The “Kindling” Effect and Repeated Withdrawals

One pattern worth understanding is that withdrawal can get worse with repetition. Each time a heavy drinker stops and then resumes, the next withdrawal episode tends to be more severe than the last. This phenomenon, often called kindling, is thought to result from the cumulative neurochemical shifts that each cycle of intoxication and withdrawal imposes on the brain. The adaptations that cause withdrawal don’t fully reset between episodes; instead, they layer on top of each other, lowering the brain’s seizure threshold further each time. The evidence bears this out clinically: having had a previous episode of severe withdrawal is the single most reliable predictor of having another one.⁸ Beyond making acute withdrawal more dangerous, these repeated neuroadaptations also contribute to heightened relapse vulnerability, making it harder and harder to stay sober with each successive attempt.² This is one reason clinicians treat early attempts at sobriety seriously and encourage people to seek help before the cycle of quitting and relapsing compounds the danger.

1
PubMed Central. Neurochemical mechanisms underlying alcohol withdrawal
2
PubMed Central. Neurochemical mechanisms of alcohol withdrawal
3
PubMed. Alcohol withdrawal and noradrenergic function
4
PubMed Central. Alcohol withdrawal syndrome: mechanisms, manifestations, and management
5
PubMed Central. Alcoholic hallucinosis
6
PubMed. Evaluation of the course and treatment of Alcohol Withdrawal Syndrome with the Clinical Institute Withdrawal Assessment for Alcohol – Revised: A systematic review-based meta-analysis
7
PubMed Central. Will this adult patient develop severe alcohol withdrawal?: The Rational Clinical Examination Systematic Review
8
PubMed. Predictors of severe alcohol withdrawal syndrome: a systematic review and meta-analysis
9
PubMed Central. Alcohol Withdrawal Syndrome: Benzodiazepines and Beyond
10
Alcohol and Alcoholism. DETOXIFICATION: THE USE OF BENZODIAZEPINES
11
PubMed. Alcohol withdrawal: what is the benzodiazepine of choice?
12
PubMed Central. Management of alcohol withdrawal syndrome in patients with alcohol-associated liver disease
13
PubMed Central. Gabapentin Use in Acute Alcohol Withdrawal Management
14
Mayo Clinic Proceedings: Innovations, Quality & Outcomes. Retrospective Analysis of Gabapentin for Alcohol Withdrawal in the Hospital Setting: The Mayo Clinic Experience
15
PubMed. Seizures in alcohol-dependent patients: epidemiology, pathophysiology and management
16
Archives of Biological Psychiatry. The importance of monitoring magnesium levels in alcohol withdrawal delirium
17
PubMed. Unpeeling the Evidence for the Banana Bag: Evidence-Based Recommendations for the Management of Alcohol-Associated Vitamin and Electrolyte Deficiencies in the ICU
18
PubMed. Effects of alcohol withdrawal on blood pressure in hypertensive heavy drinkers
19
PubMed. Effect of alcohol abstinence on blood pressure: assessment by 24-hour ambulatory blood pressure monitoring
20
PLoS One. Short-term effects of alcohol detoxification on cardiovascular, hematological, and oxidative stress biomarkers: A prospective cohort study
21
PubMed. Utilization of acute inpatient services for alcohol detoxification
22
PubMed Central. Alcohol Use Disorders in Pregnancy
23
PubMed Central. The treatment of alcohol and opioid dependence in pregnant women
24
PubMed. Disruptions in sleep time and sleep architecture in a mouse model of repeated ethanol withdrawal
25
PubMed Central. Neurobiology and Symptomatology of Post-Acute Alcohol Withdrawal: A Mixed-Studies Systematic Review
26
PubMed. Acamprosate supports abstinence, naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes
27
JAMA Psychiatry. Comparing and Combining Naltrexone and Acamprosate in Relapse Prevention of Alcoholism: A Double-blind, Placebo-Controlled Study
28
PubMed Central. Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: When are these medications most helpful?